Your browser doesn't support javascript.
loading
A case of hybrid robotic-assisted coronary artery bypass grafting and valve-in-valve transcatheter aortic valve replacement.
Yamashita, Yoshiyuki; Sicouri, Serge; Rodriguez, Roberto; Gray, William A; Sutter, Francis P; Ramlawi, Basel.
Afiliación
  • Yamashita Y; Department of Cardiothoracic Surgery Research, Lankenau Institute for Medical Research, Wynnewood, PA, USA.
  • Sicouri S; Department of Cardiothoracic Surgery Research, Lankenau Institute for Medical Research, Wynnewood, PA, USA.
  • Rodriguez R; Department of Cardiothoracic Surgery, Lankenau Heart Institute, Wynnewood, PA, USA.
  • Gray WA; Department of Interventional Cardiology, Lankenau Heart Institute, Wynnewood, PA, USA.
  • Sutter FP; Department of Cardiothoracic Surgery, Lankenau Heart Institute, Wynnewood, PA, USA.
  • Ramlawi B; Department of Cardiothoracic Surgery Research, Lankenau Institute for Medical Research, Wynnewood, PA, USA.
J Cardiol Cases ; 30(1): 12-15, 2024 Jul.
Article en En | MEDLINE | ID: mdl-39007046
ABSTRACT
We report a hybrid procedure of robotic-assisted coronary artery bypass grafting and transcatheter aortic valve-in-valve implantation for left main disease and prosthetic aortic valve stenosis. Robotic-assisted coronary artery bypass grafting using a left internal mammary artery graft was preferred to percutaneous coronary intervention because of the complex anatomy of the coronary lesion and concerns about dual antiplatelet therapy tolerance. This was followed by a valve-in-valve procedure five days later, allowing the patient to be discharged the next day. This innovative, less invasive approach demonstrates the feasibility and potential for early recovery in appropriately selected patients with complex coronary and aortic valve disease. Learning

objective:

Hybrid robotic-assisted coronary artery bypass grafting (CABG) and transcatheter aortic valve replacement (AVR) is a feasible and less invasive approach for appropriately selected patients with complex coronary and aortic valve disease who are not good candidates for percutaneous coronary intervention or conventional CABG and surgical AVR.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Cardiol Cases Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Cardiol Cases Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos